Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-16-032701)

Filing Details

Accession Number:: 0001225208-16-032701
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-05 17:29:34
Reporting Period:: 2016-05-04

Filing Date:: 2016-05-05
Accepted Time:: 2016-05-05 17:29:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1488270	M Douglas Lankler	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-05-04	1,300	$33.72	124,920	No	4	S	Direct
Common Stock	Disposition	2016-05-04	1,713	$33.69	123,207	No	4	S	Direct
Common Stock	Disposition	2016-05-04	4,318	$33.70	118,889	No	4	S	Direct
Common Stock	Disposition	2016-05-04	5,514	$33.71	113,375	No	4	S	Direct
Common Stock	Disposition	2016-05-04	5,900	$33.67	107,475	No	4	S	Direct
Common Stock	Disposition	2016-05-04	10,955	$33.68	96,520	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,352	Indirect	By Rule 16b-3 Plan